Journals / Abant Tıp Dergisi / 2020 / Cilt: 9 - Sayı: 3

Pulse Oximetry Screening Results at a Tertiary Care Center in Central-Antolia, Turkey

İç Anadolu'da Üçüncü Basamak Bir Merkezde Nabız Oksimetresi Tarama Sonuçları

Pages
99–107
Publication Date
2020-12-21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall test false positive rate was 0.6% for critical congenital heart defects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the results of the pulse oximeter screening for the early diagnosis of critical congenital heart defects in newborns in our hospital and to share our results before the implementation of a nationwide screening program.
📊
Key Findings & Data:Methods: This was a retrospective study on 2261 infants between April 2018 and January 2020.
💡
Conclusion & Impact:Overall test false positive rate was 0.6% for critical congenital heart defects.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Nabız oksimetri taraması · Konjenital kalp defektleri · Türkiye

Abstract

Purpose: To evaluate the results of the pulse oximeter screening for the early diagnosis of critical congenital heart defects in newborns in our hospital and to share our results before the implementation of a nationwide screening program. Methods: This was a retrospective study on 2261 infants between April 2018 and January 2020. Right-hand for preductal measurement and right or left foot for post-ductal measurement were measured using Nellcor pulse-oximetry (Covidien, MA, USA). Results: In 2261 newborns, the average birth week of 2261 infants was 38.05±1.32 weeks and 3204.21±478.28 g birth weight. The mean screening time was 25.9±7.3 hours (median 25 hours; min–max 7–96 hours). The mean values of the pre-ductal and post-ductal measurements of the infants who passed the test at the first measurement were 96.46±1.65 and saturation 95.99±1.49. 2247 (99.38%) of the infants included in the study underwent screening, 14 (0.61%) could not pass. Overall test false positive rate was 0.6% for critical congenital heart defects. Critical congenital heart defects was not seen in any of those who could not pass the scan. Sensitivity and positive predictive value could not be calculated, as no critical congenital heart defects case was detected. Specificity and negative predictive value of the pulse-oximetry test were 99.3% and 100% respectively. Conclusion: We highlight that screening with pulse-oximetry should be popularized particularly in peripheral regions providing secondary health care services. We are of the opinion that screening of critical congenital heart defects with pulse-oximetry should be included in the national screening program in our country.

Özet

Amaç: Hastanemizdeki yenidoğanlarda kritik konjenital kalp defektlerinin erken tanısı için nabız oksimetresi taramasının sonuçlarını değerlendirmek ve ülke çapında bir tarama programı uygulanmadan önce sonuçlarımızı paylaşmak. Yöntemler: Bu, Nisan 2018 ile Ocak 2020 arasında 2261 bebek üzerinde yapılan retrospektif bir çalışmadır. Predüktal ölçüm için sağ taraf, duktal sonrası ölçüm için sağ veya sol ayak Nellcor nabız oksimetresi (Covidien, MA, ABD) kullanılarak ölçüldü. Bulgular: 2261 yenidoğanda 2261 bebeğin ortalama doğum haftası 38.05 ± 1.32 hafta ve doğum kilosu 3204.21 ± 478.28 g idi. Ortalama tarama süresi 25.9 ± 7.3 saat idi (medyan 25 saat; min – maks 7-96 saat). İlk ölçümde testi geçen bebeklerin preduktal ve postduktal satürasyon ölçümlerinin ortalama değerleri 96.46 ± 1.65 ve 95.99 ± 1.49 idi. Çalışmaya alınan bebeklerin 2247'si (% 99,38) taramadan geçti, 14'ü (% 0,61) geçemedi. Kritik konjenital kalp defektlerinde genel test yanlış pozitif oranı % 0.6 idi. Taramayı geçemeyenlerin hiçbirinde kritik konjenital kalp defekti görülmedi. Kritik konjenital kalp defektleri vakası saptanmadığından duyarlılık ve pozitif prediktif değer hesaplanamadı. Nabız oksimetre testinin özgüllüğü ve negatif prediktif değeri sırasıyla% 99.3 ve% 100 idi. Sonuç: Nabız oksimetreli taramanın özellikle ikinci basamak sağlık hizmeti sunan perifer bölgelerde yaygınlaştırılması gerektiğinin altını çiziyoruz. Kritik konjenital kalp defektlerinin nabız oksimetresi ile taranmasının ülkemizdeki ulusal tarama programına dahil edilmesi gerektiğine inanıyoruz.

🔖

Cite This Article

YILMAZ, F. H., TARAKÇI, N., OFLAZ, M. B., ALTUNHAN, H. (2020). Pulse Oximetry Screening Results at a Tertiary Care Center in Central-Antolia, Turkey. Abant Tıp Dergisi, Cilt: 9 - Sayı: 3, 99–107. https://ajindex.com/articles/448851

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tennant PW, Pearce MS, Bythell M, Rankin J. 20-year survival of children born with congenital anomalies: a population-based study. Lancet. 2010;375:649–56
  2. Frank LH, Bradshaw E, Beekman R, et al. Critical congenital heart disease screening using pulse-oximetry. J Pediatr 2013; 162: 445–453
  3. Ailes EC, Gilboa SM, Honein MA, Oster ME. Estimated number of infants detected and missed by critical congenital heart defect screening. Pediatrics. 2015;135:1000–8
  4. Bruno CJ, Havranek T. Screening for critical congenital heart disease in newborns. Adv Pediatr. 2015;62(1):211–26
  5. Peterson C, Ailes E, Riehle-Colarusso T et al. Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse-oximetry. JAMA Pediatr. 2014;168(4):361–70. 6. de-Wahl Granelli A, Wennergren M, Sandberg K, et al. Impact of pulse-oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39, 821 newborns. BMJ 2009; 338: 3037
  6. Hoffman JI. It is time for routine neonatal screening by pulse-oximetry. Neonatology 2011; 99: 1–9
  7. Kemper AR, Mahle WT, Martin GR, et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics 2011; 128: 1259–1267
  8. Ewer AK. Screening for critical congenital heart defects with pulse-oximetry: medical aspects. Am J Perinatol 2016; 33: 1062–1066
  9. Thangaratinam S, Brown K, Zamora J, et al. Pulse-oximetry screening for critical congenital heart defects in asymptomatic newborn infants: a systematic review and metaanalysis. Lancet 2012; 379: 2459–2464
  10. Zhao QM, Ma XJ, Ge XL, et al. Pulse-oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet 2014; 384: 747–754. Erratum in: Lancet. 2014; 384:746
  11. Ewer AK, Middleton LJ, Furmston AT et al. Pulse-oximetry screening for congenital heart defect in newborn infants (PuseOx): A test accuracy study. Lancet 2011; 378(9793): 785-794
  12. Walsh W. Evaluation of pulse-oximetry screening in middle tennessee cases for consideration before universal screening. J Perinatol 2011; 31(2): 125-129
  13. Narayen IC, Blom NA, Ewer AK et al. Aspects of pulse-oximetry screening for critical congenital heart defects: when, how and why? Arch Dis Child Fetal Neonatal Ed. 2016;101:F162–7
  14. Turska Kmiec´ A, Borszewska Kornacka MK, Błaz W, et al. Early screening for critical congeni